447
AnaptysBio, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
Assets
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
407
FY24:
432
FY25:
350
FY26:
198
(positive)
Change from FY22 to FY26
millions USD
FY22:
163
FY23:
45.6
FY24:
52.0
FY25:
14.1
FY26:
119
Total assets
Change from FY22 to FY26
millions USD
FY22:
610
FY23:
452
FY24:
484
FY25:
364
FY26:
317
Liabilities & Equity
(negative)
Change from FY22 to FY26
millions USD
FY22:
26.1
FY23:
37.4
FY24:
45.4
FY25:
38.6
FY26:
35.4
(negative)
Change from FY22 to FY25
millions USD
FY22:
322
FY23:
327
FY24:
368
FY25:
289
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
262
FY23:
88.1
FY24:
70.9
FY25:
37.2
FY26:
10.6
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
610
FY23:
452
FY24:
484
FY25:
364
FY26:
–
All amounts in millions USD